Why labs choose Remy Peptides

Every released Retatrutide batch carries a published Janoshik Analytical Certificate of Analysis. Current published purity ranges from 99.262% HPLC on the flagship 30mg pen (batch RETP002) to 99.841% HPLC on the 20mg pen (batch RET-20-C-2604-001, our highest published Remy batch).

Standard research-grade peptide purity sits in the 95–99% range per public references from GenScript, IonPeptide, and Proto Peptide. We publish at the top of that range with a task ID and verification key that buyers can punch into janoshik.com to pull the raw report off the lab’s server. The full archive is at the Raw COA archive and the per-SKU explainer layer at the Lab Results hub.

HPLC sorts peptide species by retention time but does not see water, salts, residual organic solvents, or bacterial endotoxin. For the Retatrutide vial line (batch RET-20-V-2604-001) we publish a fuller Janoshik panel:

• 99.741% HPLC purity, 20.92 mg assay
• Heavy metals (As, Cd, Pb, Hg) — not detected
• Residual TFA — not detected
• Bacterial endotoxin — 1.449 EU/Vial (LAL method)

Endotoxin testing is the sterility benchmark pharma uses for parenteral compounds. Most research peptide sellers stop at HPLC; the vial line is the only Retatrutide batch family on the UAE market with the complete panel published.

Orders placed before 4 PM Dubai time dispatch same-day with insulated cold-chain packaging. Delivery windows:

• Dubai: 2–4 hours same-day
• Abu Dhabi, Sharjah, Ajman: next-day
• RAK, Fujairah, UAQ: next-day to 48 hours

Cold-chain integrity is maintained from our Al Barsha 1 warehouse to the door. Geo-targeted ordering pages: Dubai, UAE overview, Abu Dhabi, Sharjah.

Remy Peptides operates under UAE MoHAP Circular 17/2022, which permits the supply of research peptides for in-vitro laboratory use only. Our catalog, labelling, and product communications are scoped accordingly — the full terms are spelled out in the disclaimer and reinforced on every page via the persistent compliance banner.

Buyer framing is consistent across the site: licensed researchers, laboratory professionals, and institutional buyers ordering for legitimate scientific work. No therapeutic, treatment, cure, or human-use claims appear in product copy.

Every active Remy Peptides contact channel can be confirmed against the canonical list at /contact-verify/. Channel rotation is rare and always documented there with timestamps. Current active channels:

• WhatsApp: +351 924 694 686
• Telegram: @RemyPeptides
• Email: info@remypeptides.com
• Instagram: @remypeptides

Address: Pinnacle Building, Al Barsha 1, Dubai, UAE.

The research library currently carries 81 English-language articles on peptide pharmacology, trial trackers, dosage and reconstitution math, COA interpretation, and regulatory context. Most-referenced entries:

• How to read a peptide COA — field-by-field walkthrough
• How to verify a Janoshik COA — task IDs and verification keys
• Retatrutide pen-clicks guide — mg-to-click lookup
• Reconstitution calculator — custom dose planning

All content is reviewed against the catalog every refresh cycle; the most recent library refresh was 13 May 2026.

All prices are published in AED with explicit tier breakdowns on every product page. No surprise fees at checkout. Volume tiers are visible upfront. Free UAE cold-chain delivery is included on every order with no minimum — the OfferShippingDetails schema on each product page now explicitly labels this for AI surfaces.

Stock status is shown in real time on each product page. Items currently in stock as of May 2026 include the full Retatrutide line (30mg / 20mg / 10mg pens, 10mg / 40mg vials), GLOW 50/10/10 vial and 70mg pen, and the secondary vial catalog (SS-31, BPC-157, TB-500, GHK-Cu, MOTS-C, AOD-9604, KPV, CJC-1295/Ipamorelin blend, HCG, PT-141, bacteriostatic water).